What side effects are associated with this type of intervention?

Behavioral support via text messaging, such as SmokefreeTXT, generally has minimal side effects, primarily involving the potential for increased screen time and possible message fatigue. Pharmacotherapy options like nicotine replacement therapy (NRT) can cause side effects such as skin irritation (patches), mouth or throat irritation (lozenges, gum), and nasal irritation (nasal spray). Bupropion may lead to insomnia, dry mouth, and, in rare cases, seizures. Varenicline can cause nausea, vivid dreams, and, less commonly, mood changes. Counseling and behavioral interventions typically have no direct physical side effects but may require significant time and emotional investment.

What prior FDA approvals exist?

The FDA has approved several pharmacotherapies for smoking cessation, including varenicline, bupropion, and various forms of nicotine replacement therapies (NRTs) such as patches, lozenges, and gum. Behavioral support methods, particularly those delivered via text messaging like the SmokefreeTXT program, have also been shown to be effective in aiding smoking cessation. These text-based interventions provide continuous support and have been demonstrated to double the rates of biochemically verified abstinence at six months.

What other types of research exist?

Promising, novel alternatives to SmokefreeTXT for smoking cessation include: 1) Quit4baby, an interactive and intensive text messaging program specifically for pregnant women; 2) COach2Quit, a smartphone application that combines exhaled carbon monoxide readings with message support; 3) SmokefreeMOM, an automated text-messaging program for pregnant smokers; and 4) smartphone applications that incorporate behavior change techniques (BCTs) for a more comprehensive approach to smoking cessation.

← Back to Search

Behavioral Intervention

Text Messaging Program for Smoking Cessation

N/A

Waitlist Available

Research Sponsored by University of Virginia

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age 18 and over

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Summary

This trialwill test if a text messaging program to help people quit smoking is effective in different parts of Virginia. Participants will be asked to use the program and complete assessments.

Who is the study for?

This trial is for adult smokers in Virginia who have smoked at least 100 cigarettes in their lifetime and currently smoke. They must own a cell phone, be able to read and speak English, and not be pregnant or planning pregnancy within six months. Those already attempting to quit smoking or living in an area with enough participants are excluded.Check my eligibility

What is being tested?

The study tests SmokefreeTXT, a text messaging program designed to help people stop smoking. Participants will use the research version of this service while researchers track their progress across several regions of Virginia through assessments over a six-month period.See study design

What are the potential side effects?

Since SmokefreeTXT is a non-medical intervention involving text messages for smoking cessation support, there are no direct medical side effects associated with its use.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Secondary outcome measures

Self-reported continuous abstinence

Smoke

Trial Design

1Treatment groups

Experimental Treatment

Group I: SmokfreeTXTExperimental Treatment1 Intervention

Research version of the publicly available SmokefreeTXT program

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

SmokefreeTXT

2018

Completed Phase 4

~1390

0 / 1Eligibility criteria met

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.

Mechanism Of Action

Side Effect Profile

Prior Approvals

Other Research

Common smoking cessation treatments work through both behavioral and pharmacologic mechanisms. Behavioral support, such as text messaging programs like SmokefreeTXT, provides real-time encouragement, coping strategies, and reminders to help manage cravings and maintain motivation. Pharmacologic treatments, including nicotine replacement therapy (NRT) and medications like varenicline, reduce withdrawal symptoms and decrease the rewarding effects of nicotine. This combination is particularly effective because it addresses both the psychological and physical aspects of nicotine dependence, offering a comprehensive approach to quitting smoking.

Mindfulness-Based Smoking Cessation Delivered Through Telehealth and Text Messaging for Low-Income Smokers: Protocol for a Randomized Controlled Trial.The natural history of efforts to stop smoking: a prospective cohort study.Randomized controlled trial of behavioral activation smoking cessation treatment for smokers with elevated depressive symptoms.

Find a Location

Who is running the clinical trial?

University of VirginiaLead Sponsor

761 Previous Clinical Trials

1,255,989 Total Patients Enrolled

Media Library

SmokefreeTXT (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05055778 — N/A

Smoking Cessation Research Study Groups: SmokfreeTXT

Smoking Cessation Clinical Trial 2023: SmokefreeTXT Highlights & Side Effects. Trial Name: NCT05055778 — N/A

SmokefreeTXT (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05055778 — N/A

~13 spots leftby Jul 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.